{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:49:28Z","timestamp":1792183768318,"version":"4.4.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s11904-008-0002-8","type":"journal-article","created":{"date-parts":[[2008,1,31]],"date-time":"2008-01-31T14:05:14Z","timestamp":1201788314000},"page":"5-12","source":"Crossref","is-referenced-by-count":50,"title":["Oral manifestations associated with HIV infection"],"prefix":"10.1007","volume":"5","author":[{"given":"Mostafa","family":"Nokta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,2,1]]},"reference":[{"key":"2_CR1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0966-842X(01)02094-7","volume":"9","author":"R.A. Calderone","year":"2001","unstructured":"Calderone RA, Fonzi WA: Virulence factors of Candida albicans. Trends Microbiol 2001, 9:327\u2013335.","journal-title":"Trends Microbiol"},{"key":"2_CR2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/1087291041703665","volume":"18","author":"J.E. Leigh","year":"2004","unstructured":"Leigh JE, Shetty K, Fidel PL Jr: Oral opportunistic infections in HIV-positive individuals: review and role of mucosal immunity. AIDS Patient Care STDS 2004, 18:443\u2013456","journal-title":"AIDS Patient Care STDS"},{"key":"2_CR3","first-page":"143","volume":"13","author":"D.A. Reznik","year":"2006","unstructured":"Reznik DA: Oral manifestations of HIV disease. Top HIV Med 2006, 13:143\u2013148.","journal-title":"Top HIV Med"},{"key":"2_CR4","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0140-6736(84)90872-9","volume":"2","author":"D. Greenspan","year":"1984","unstructured":"Greenspan D, Greenspan JS, Conant M, et al.: Oral \u201chairy\u201d leukoplakia in male homosexuals: evidence of association with both papillomavirus and a herpes-group virus. Lancet 1984, 2:831\u2013834.","journal-title":"Lancet"},{"key":"2_CR5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1034\/j.1601-0825.2001.70108.x","volume":"7","author":"P. Ammatuna","year":"2001","unstructured":"Ammatuna P, Campisi G, Giovannelli L, et al.: Presence of Epstein-Barr virus, cytomegalovirus and human papillomavirus in normal oral mucosa of HIV-infected and renal transplant patients. Oral Dis 2001, 7:34\u201340.","journal-title":"Oral Dis"},{"key":"2_CR6","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1001\/archinte.1996.00440180113014","volume":"156","author":"C.H. Shiboski","year":"1996","unstructured":"Shiboski CH, Hilton JF, Neuhaus JM, et al.: Human immunodeficiency virus-related oral manifestations and gender. A longitudinal analysis. Arch Intern Med 1996, 156:2249\u20132254.","journal-title":"Arch Intern Med"},{"key":"2_CR7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1600-0714.1998.tb01979.x","volume":"27","author":"P. Ammatuna","year":"1998","unstructured":"Ammatuna P, Capone F, Giambelluca D, et al.: Detection of Epstein-Barr virus (EBV) DNA and antigens in oral mucosa of renal transplant patients without clinical evidence of oral hairy leukoplakia (OHL). J Oral Pathol Med 1998, 27:420\u2013427.","journal-title":"J Oral Pathol Med"},{"key":"2_CR8","doi-asserted-by":"crossref","first-page":"9645","DOI":"10.1128\/JVI.76.19.9645-9656.2002","volume":"76","author":"D. Sitki-Green","year":"2002","unstructured":"Sitki-Green, D, Edwards RH, Webster-Cyriaque J, Raab-Traub N: Identification of Epstein-Barr virus strain variants in hairy leukoplakia and peripheral blood by use of a heteroduplex tracking assay. J Virol 2002, 76:9645\u20139656.","journal-title":"J Virol"},{"key":"2_CR9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/10428190400007789","volume":"46","author":"C. Cattaneo","year":"2005","unstructured":"Cattaneo C, Facchetti F, Re A, et al.: Oral cavity lymphomas in immunocompetent and human immunodeficiency virus infected patients. Leuk Lymphoma 2005, 46:77\u201381.","journal-title":"Leuk Lymphoma"},{"key":"2_CR10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1034\/j.1601-0825.2003.01808.x","volume":"9","author":"A. Iamaroon","year":"2003","unstructured":"Iamaroon A, Pongsiriwet S, Mahanupab P, et al.: Oral non-Hodgkin lymphomas: studies of EBV and p53 expression. Oral Dis 2003, 9:14\u201318.","journal-title":"Oral Dis"},{"key":"2_CR11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0030-4220(92)90107-2","volume":"73","author":"C.L. Dodd","year":"1992","unstructured":"Dodd CL, Greenspan D, Schi\u00f8dt M, et al.: Unusual oral presentation of non-Hodgkin\u2019s lymphoma in association with HIV infection. Oral Surg Oral Med Oral Pathol 1992, 73:603\u2013608.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"2_CR12","first-page":"657","volume":"16","author":"A.E. Gates","year":"2002","unstructured":"Gates AE, Kaplan LD: AIDS malignancies in the era of highly active antiretroviral therapy. Oncology (Williston Park) 2002, 16: 657\u2013665, 668\u2013670.","journal-title":"Oncology (Williston Park)"},{"key":"2_CR13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3816\/CLM.2003.n.016","volume":"4","author":"C. Thirlwell","year":"2003","unstructured":"Thirlwell C, Sarker D, Stebbing J, Bower M: Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapy. Clin Lymphoma 2003, 4:86\u201392.","journal-title":"Clin Lymphoma"},{"key":"2_CR14","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1368-8375(01)00100-2","volume":"38","author":"V. Ramirez-Amador","year":"2002","unstructured":"Ramirez-Amador V, Esquivel-Pedraza L, Lozada-Nur F, et al.: Intralesional vinblastine vs 3% sodium tetradecyl sulfate for the treatment of oral Kaposi\u2019s sarcoma. A double blind, randomized clinical trial. Oral Oncol 2002, 38:460\u2013467.","journal-title":"Oral Oncol"},{"key":"2_CR15","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0959-8049(01)00109-5","volume":"37","author":"A.M. Levine","year":"2001","unstructured":"Levine AM, Tulpule A: Clinical aspects and management of AIDS-related Kaposi\u2019s sarcoma. Eur J Cancer 2001, 37:1288\u20131295.","journal-title":"Eur J Cancer"},{"key":"2_CR16","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/thx.47.9.730","volume":"47","author":"A.L. Pozniak","year":"1992","unstructured":"Pozniak AL, Latif AS, Neill P, et al.: Pulmonary Kaposi\u2019s sarcoma in Africa. Thorax 1992, 47:730\u2013733.","journal-title":"Thorax"},{"key":"2_CR17","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1128\/JVI.78.8.4074-4084.2004","volume":"78","author":"K.M. Duus","year":"2004","unstructured":"Duus KM, Lentchitsky V, Wagenaar T, et al.: Wild-type Kaposi\u2019s sarcoma-associated herpesvirus isolated from the oropharynx of immune-competent individuals has tropism for cultured oral epithelial cells. J Virol 2004, 78:4074\u20134084.","journal-title":"J Virol"},{"key":"2_CR18","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1056\/NEJM200011093431904","volume":"343","author":"J. Pauk","year":"2000","unstructured":"Pauk J, Huang ML, Brodie SJ, et al.: Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 2000, 343:1369\u20131377.","journal-title":"N Engl J Med"},{"key":"2_CR19","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1086\/424489","volume":"190","author":"S.M. Mbulaiteye","year":"2004","unstructured":"Mbulaiteye SM, Pfeiffer RM, Engels EA, et al.: Detection of Kaposi sarcoma-associated herpesvirus DNA in saliva and buffy-coat samples from children with sickle cell disease in Uganda. J Infect Dis 2004, 190:1382\u20131386.","journal-title":"J Infect Dis"},{"key":"2_CR20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/rmv.341","volume":"12","author":"L. Corey","year":"2002","unstructured":"Corey, L, Brodie S, Huang ML, et al.: HHV-8 infection: a model for reactivation and transmission. Rev Med Virol 2002, 12:47\u201363.","journal-title":"Rev Med Virol"},{"key":"2_CR21","doi-asserted-by":"crossref","first-page":"13769","DOI":"10.1128\/JVI.79.21.13769-13777.2005","volume":"79","author":"A.S. Johnson","year":"2005","unstructured":"Johnson AS, Maronian N, Vieira J: Activation of Kaposi\u2019s sarcoma-associated herpesvirus lytic gene expression during epithelial differentiation. J Virol 2005, 79:13769\u201313777.","journal-title":"J Virol"},{"key":"2_CR22","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1038\/sj.onc.1206555","volume":"22","author":"J.T. West","year":"2003","unstructured":"West JT, Wood C: The role of Kaposi\u2019s sarcoma-associated herpesvirus\/human herpesvirus-8 regulator of transcription activation (RTA) in control of gene expression. Oncogene 2003, 22:5150\u20135163.","journal-title":"Oncogene"},{"key":"2_CR23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1172\/JCI200417803","volume":"113","author":"A. Grundhoff","year":"2004","unstructured":"Grundhoff A, Ganem D: Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest 2004, 113:124\u2013136.","journal-title":"J Clin Invest"},{"key":"2_CR24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.canlet.2005.10.029","volume":"241","author":"J.W. Jung","year":"2006","unstructured":"Jung JW, Cho SD, Ahn NS, et al.: Effects of the histone deacetylases inhibitors sodium butyrate and trichostatin A on the inhibition of gap junctional intercellular communication by H2O2-and 12-O-tetradecanoylphorbol-13-acetate in rat liver epithelial cells. Cancer Lett 2006, 241:301\u2013308.","journal-title":"Cancer Lett"},{"key":"2_CR25","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.1128\/JVI.02504-06","volume":"81","author":"T.L. Morris","year":"2007","unstructured":"Morris TL, Arnold RR, Webster-Cyriaque J: Signaling cascades triggered by bacterial metabolic end products during reactivation of Kaposi\u2019s sarcoma-associated herpesvirus. J Virol 2007, 81:6032\u20136042.","journal-title":"J Virol"},{"key":"2_CR26","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1056\/NEJMoa065497","volume":"356","author":"G. D\u2019souza","year":"2007","unstructured":"D\u2019souza G, Kreimer AR, Viscidi R, et al.: Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007, 356:1944\u20131956.","journal-title":"N Engl J Med"},{"key":"2_CR27","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/381504","volume":"189","author":"A.R. Kreimer","year":"2004","unstructured":"Kreimer AR, Alberg AJ, Daniel R, et al.: Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 2004, 189:686\u2013698.","journal-title":"J Infect Dis"},{"key":"2_CR28","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(00)04578-5","volume":"357","author":"D. Greenspan","year":"2001","unstructured":"Greenspan D, Canchola AJ, MacPhail LA, et al.: Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 2001, 357:1411\u20131412.","journal-title":"Lancet"},{"key":"2_CR29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1399-302X.2005.00198.x","volume":"20","author":"E.A. Lilly","year":"2005","unstructured":"Lilly EA, Cameron JE, Shetty KV, et al.: Lack of evidence for local immune activity in oral hairy leukoplakia and oral wart lesions. Oral Microbiol Immunol 2005, 20:154\u2013162.","journal-title":"Oral Microbiol Immunol"},{"key":"2_CR30","doi-asserted-by":"crossref","unstructured":"1999 International Workshop for a Classification of Periodontal Diseases and Conditions. Papers. Oak Brook, Illinois, October 30\u2013November 2, 1999. Ann Periodontol 1999, 4:i, 1\u2013112.","DOI":"10.1902\/annals.1999.4.1.1"},{"key":"2_CR31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1600-0757.2006.00174.x","volume":"42","author":"B.J. Paster","year":"2006","unstructured":"Paster BJ, Olsen I, Aas JA, Dewhirst FE: The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol 2000 2006, 42:80\u201387.","journal-title":"Periodontol 2000"},{"key":"2_CR32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-0757.2005.00112.x","volume":"38","author":"A.D. Haffajee","year":"2005","unstructured":"Haffajee AD, Socransky SS: Microbiology of periodontal diseases: introduction. Periodontol 2000 2005, 38:9\u201312.","journal-title":"Periodontol 2000"},{"key":"2_CR33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0757.2005.00113.x","volume":"38","author":"S.C. Holt","year":"2005","unstructured":"Holt SC, Ebersole JL: Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the \u201cred complex\u201d, a prototype polybacterial pathogenic consortium in periodontitis. Periodontol 2000 2005, 38:72\u2013122.","journal-title":"Periodontol 2000"},{"key":"2_CR34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1600-0757.2005.00107.x","volume":"38","author":"S.S. Socransky","year":"2005","unstructured":"Socransky SS, Haffajee AD: Periodontal microbial ecology. Periodontol 2000 2005, 38:135\u2013187.","journal-title":"Periodontol 2000"},{"key":"2_CR35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1600-051X.2006.01034.x","volume":"34","author":"J.A. Aas","year":"2007","unstructured":"Aas JA, Barbuto SM, Alpagot T, et al.: Subgingival plaque microbiota in HIV positive patients. J Clin Periodontol 2007, 34:189\u2013195.","journal-title":"J Clin Periodontol"},{"key":"2_CR36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1600-0757.2005.00109.x","volume":"38","author":"J. Slots","year":"2005","unstructured":"Slots J: Herpesviruses in periodontal diseases. Periodontol 2000 2005, 38:33\u201362.","journal-title":"Periodontol 2000"},{"key":"2_CR37","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/QCO.0b013e3280964da0","volume":"20","author":"J. Slots","year":"2007","unstructured":"Slots J: Herpesviral-bacterial synergy in the pathogenesis of human periodontitis. Curr Opin Infect Dis 2007, 20:278\u2013283.","journal-title":"Curr Opin Infect Dis"},{"key":"2_CR38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.0906-6713.2003.003432.x","volume":"34","author":"E.F. Corbet","year":"2004","unstructured":"Corbet EF: Diagnosis of acute periodontal lesions. Periodontol 2000 2004, 34:204\u2013216.","journal-title":"Periodontol 2000"},{"key":"2_CR39","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199705223362103","volume":"336","author":"J.M. Jacobson","year":"1997","unstructured":"Jacobson JM, Greenspan JS, Spritzler J, et al.: Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med 1997, 336:1487\u20131493.","journal-title":"N Engl J Med"},{"key":"2_CR40","first-page":"1","volume":"15","author":"K. Shetty","year":"2003","unstructured":"Shetty K: Thalidomide for recurrent aphthous ulcerations. HIV Clin 2003, 15:1, 4\u20136.","journal-title":"HIV Clin"},{"key":"2_CR41","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1468-3083.2006.01812.x","volume":"21","author":"J. Dalmau","year":"2007","unstructured":"Dalmau J, Alegre M, Domingo P, Alomar A: Major oral aphthous ulceration in HIV-1 infection: successful response after highly active antiretroviral therapy. J Eur Acad Dermatol Venereol 2007, 21:126\u2013127.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2_CR42","first-page":"34","volume":"18","author":"J. Mitchell","year":"2006","unstructured":"Mitchell J: Meth abuse causes extensive dental decay. Todays FDA 2006, 18:34\u201335.","journal-title":"Todays FDA"},{"key":"2_CR43","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/apc.2006.20.146","volume":"20","author":"J.W. Shaner","year":"2006","unstructured":"Shaner JW, Kimmes N, Saini T, Edwards P: \u201cMeth mouth\u201d: rampant caries in methamphetamine abusers. AIDS Patient Care STDS 2006, 20:146\u2013150.","journal-title":"AIDS Patient Care STDS"},{"issue":"Suppl2","key":"2_CR44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1034\/j.1601-0825.2002.00012.x","volume":"8","author":"F. Ramos-Gomez","year":"2002","unstructured":"Ramos-Gomez F: Dental considerations for the paediatric AIDS\/HIV patient. Oral Dis 2002, 8(Suppl 2):49\u201354.","journal-title":"Oral Dis"},{"key":"2_CR45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1354-523X.2003.00973.x","volume":"10","author":"S. Naidoo","year":"2004","unstructured":"Naidoo S, Chikte U: Oro-facial manifestations in paediatric HIV: a comparative study of institutionalized and hospital outpatients. Oral Dis 2004, 10:13\u201318.","journal-title":"Oral Dis"},{"key":"2_CR46","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0896-8411(89)90170-4","volume":"2","author":"M. Schi\u00f8dt","year":"1989","unstructured":"Schi\u00f8dt M, Greenspan D, Daniels TE, et al.: Parotid gland enlargement and xerostomia associated with labial sialadenitis in HIV-infected patients. J Autoimmun 1989, 2:415\u2013425.","journal-title":"J Autoimmun"},{"key":"2_CR47","first-page":"33","volume":"71","author":"A. Pinto","year":"2004","unstructured":"Pinto A, De Rossi SS: Salivary gland disease in pediatric HIV patients: an update. J Dent Child (Chic) 2004, 71:33\u201337.","journal-title":"J Dent Child (Chic)"},{"key":"2_CR48","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1600-0714.2005.00337.x","volume":"34","author":"C. Frezzini","year":"2005","unstructured":"Frezzini C, Leao JC, Porter S: Current trends of HIV disease of the mouth. J Oral Pathol Med 2005, 34:513\u2013531.","journal-title":"J Oral Pathol Med"},{"issue":"Suppl1","key":"2_CR49","first-page":"S94","volume":"111","author":"N.L. Harris","year":"1999","unstructured":"Harris NL: Lymphoid proliferations of the salivary glands. Am J Clin Pathol 1999, 111(1 Suppl 1):S94\u2013S103.","journal-title":"Am J Clin Pathol"},{"key":"2_CR50","first-page":"700","volume":"83","author":"M.M. Coogan","year":"2005","unstructured":"Coogan MM, Greenspan J, Challacombe SJ: Oral lesions in infection with human immunodeficiency virus. Bull World Health Organ 2005, 83:700\u2013706.","journal-title":"Bull World Health Organ"},{"key":"2_CR51","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/154407370601900121","volume":"19","author":"T.A. Hodgson","year":"2006","unstructured":"Hodgson TA, Naidoo S, Chidzonga M, et al.: (A1) Identification of oral health care needs in children and adults, management of oral diseases. Adv Dent Res 2006, 19:106\u2013117.","journal-title":"Adv Dent Res"},{"key":"2_CR52","first-page":"479","volume":"25","author":"J.W. Chen","year":"2003","unstructured":"Chen JW, Flaitz CM, Wullbrandt B, Sexton J: Association of dental health parameters with oral lesion prevalence in human immunodeficiency virus-infected Romanian children. Pediatr Dent 2003, 25:479\u2013484.","journal-title":"Pediatr Dent"},{"key":"2_CR53","first-page":"395","volume":"66","author":"F.J. Ramos-Gomez","year":"1999","unstructured":"Ramos-Gomez FJ, Tomar SL, Ellison J, et al.: Assessment of early childhood caries and dietary habits in a population of migrant Hispanic children in Stockton, California. ASDC J Dent Child 1999, 66:395\u2013403.","journal-title":"ASDC J Dent Child"},{"key":"2_CR54","first-page":"44","volume":"23","author":"C. Flaitz","year":"2001","unstructured":"Flaitz C, Wullbrandt B, Sexton J, et al.: Prevalence of orodental findings in HIV-infected Romanian children. Pediatr Dent 2001, 23:44\u201350.","journal-title":"Pediatr Dent"},{"key":"2_CR55","first-page":"260","volume":"23","author":"M.J. Hauk","year":"2001","unstructured":"Hauk MJ, Moss ME, Weinberg GA, Berkowitz RJ: Delayed tooth eruption: association with severity of HIV infection. Pediatr Dent 2001, 23:260\u2013262.","journal-title":"Pediatr Dent"},{"key":"2_CR56","first-page":"101","volume":"13","author":"D.C. Futterman","year":"2005","unstructured":"Futterman DC: HIV in adolescents and young adults: half of all new infections in the United States. Top HIV Med 2005, 13:101\u2013105.","journal-title":"Top HIV Med"},{"key":"2_CR57","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-3016.2006.00742.x","volume":"20","author":"D. Freedman","year":"2006","unstructured":"Freedman D, Koenig LJ, Wiener J, et al.: Challenges to re-enrolling perinatally HIV-infected and HIV-exposed but uninfected children into a prospective cohort study: strategies for locating and recruiting hard-to-reach families. Paediatr Perinat Epidemiol 2006, 20:338\u2013347.","journal-title":"Paediatr Perinat Epidemiol"},{"key":"2_CR58","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/154405910708600305","volume":"86","author":"F.X. Lu","year":"2007","unstructured":"Lu FX, Jacobson RS: Oral mucosal immunity and HIV\/SIV infection. J Dent Res 2007, 86:216\u2013226.","journal-title":"J Dent Res"},{"key":"2_CR59","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1128\/CDLI.00426-05","volume":"13","author":"S.H. Kazmi","year":"2006","unstructured":"Kazmi SH, Naglik JR, Sweet SP, et al.: Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids. Clin Vaccine Immunol 2006, 13:1111\u20131118.","journal-title":"Clin Vaccine Immunol"},{"key":"2_CR60","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/154407370601900107","volume":"19","author":"S.J. Challacombe","year":"2006","unstructured":"Challacombe SJ, Naglik JR: The effects of HIV infection on oral mucosal immunity. Adv Dent Res 2006, 19:29\u201335.","journal-title":"Adv Dent Res"},{"key":"2_CR61","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/154407370601900109","volume":"19","author":"A. Weinberg","year":"2006","unstructured":"Weinberg A, Quinones-Mateu ME, Lederman MM: Role of human beta-defensins in HIV infection. Adv Dent Res 2006, 19:42\u201348.","journal-title":"Adv Dent Res"},{"key":"2_CR62","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00042560-200208010-00007","volume":"30","author":"C. Devito","year":"2002","unstructured":"Devito C, Hinkula J, Kaul R, et al.: Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects. J Acquir Immune Defic Syndr 2002, 30:413\u2013420.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2_CR63","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1196\/annals.1384.024","volume":"1098","author":"Z. Chen","year":"2007","unstructured":"Chen Z, Mauk MG, Wang J, et al.: A microfluidic system for saliva-based detection of infectious diseases. Ann N Y Acad Sci 2007, 1098:429\u2013436.","journal-title":"Ann N Y Acad Sci"},{"key":"2_CR64","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1128\/JVI.77.6.3470-3476.2003","volume":"77","author":"X. Liu","year":"2003","unstructured":"Liu X, Zha J, Chen H, et al.: Human immunodeficiency virus type 1 infection and replication in normal human oral keratinocytes. J Virol 2003, 77:3470\u20133476.","journal-title":"J Virol"},{"key":"2_CR65","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.1128\/JVI.00042-07","volume":"81","author":"J.M. Milush","year":"2007","unstructured":"Milush JM, Stefano-Cole K, Schmidt K, et al.: Mucosal innate immune response associated with a timely humoral immune response and slower disease progression after oral transmission of simian immunodeficiency virus to rhesus macaques. J Virol 2007, 81:6175\u20136186.","journal-title":"J Virol"},{"key":"2_CR66","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1126\/science.285.5431.1261","volume":"285","author":"C. Stahl-Hennig","year":"1999","unstructured":"Stahl-Hennig C, Steinman RM, Tenner-Racz K, et al.: Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus. Science 1999, 285:1261\u20131265.","journal-title":"Science"},{"key":"2_CR67","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.1128\/JVI.02240-05","volume":"80","author":"K. Abel","year":"2006","unstructured":"Abel K, Pahar B, Van Rompay KK, et al.: Rapid virus dissemination in infant macaques after oral simian immunodeficiency virus exposure in the presence of local innate immune responses. J Virol 2006, 80:6357\u20136367.","journal-title":"J Virol"},{"key":"2_CR68","first-page":"2371","volume":"18","author":"J.M. Milush","year":"2004","unstructured":"Milush JM, Kosub D, Marthas M, et al.: Rapid dissemination of SIV following oral inoculation. AIDS 2004, 18:2371\u20132380.","journal-title":"AIDS"},{"key":"2_CR69","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-1702(01)00396-3","volume":"82","author":"P. Lundholm","year":"2002","unstructured":"Lundholm P, Leandersson AC, Christensson B, et al.: DNA mucosal HIV vaccine in humans. Virus Res 2002, 82:141\u2013145.","journal-title":"Virus Res"},{"key":"2_CR70","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1099\/vir.0.79869-0","volume":"85","author":"B. Makitalo","year":"2004","unstructured":"Makitalo B, Lundholm P, Hinkula J, et al.: Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen. J Gen Virol 2004, 85:2407\u20132419.","journal-title":"J Gen Virol"},{"key":"2_CR71","doi-asserted-by":"crossref","unstructured":"Stahl-Hennig C, Kuate S, Franz M, et al.: Atraumatic oral spray immunization with replication-deficient viral vector vaccines. J Virol 2007, [Epub ahead of print.]","DOI":"10.1128\/JVI.01400-07"},{"key":"2_CR72","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00000441-200407000-00008","volume":"328","author":"M.E. Hagensee","year":"2004","unstructured":"Hagensee ME, Cameron JE, Leigh JE, Clark RA: Human papillomavirus infection and disease in HIV-infected individuals. Am J Med Sci 2004, 328:57\u201363.","journal-title":"Am J Med Sci"},{"key":"2_CR73","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-200003100-00005","volume":"14","author":"P. Tebas","year":"2000","unstructured":"Tebas P, Powderly WG, Claxton S, et al.: Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 2000, 14:F63\u2013F67.","journal-title":"AIDS"},{"key":"2_CR74","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/aid.2006.0084","volume":"23","author":"A.P. Malizia","year":"2007","unstructured":"Malizia AP, Cotter E, Chew N, et al.: HIV protease inhibitors selectively induce gene expression alterations associated with reduced calcium deposition in primary human osteoblasts. AIDS Res Hum Retroviruses 2007, 23:243\u2013250.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2_CR75","first-page":"1","volume":"17","author":"Centers for Disease ControlPrevention","year":"2005","unstructured":"Centers for Disease Control and Prevention: HIV\/AIDS Surveillance Report. US Department of Health and Human Services 2005, 17:1\u201354. http:\/\/www.cdc.gov\/hiv\/topics\/surveillance\/resources\/reports\/2005report .","journal-title":"HIV\/AIDS Surveillance Report. US Department of Health and Human Services"},{"key":"2_CR76","first-page":"121","volume":"55","author":"CDC","year":"2006","unstructured":"CDC: Racial\/ethnic disparities in diagnoses of HIV\/AIDS-33 states, 2001\u20132004. MMWR Morb Mortal Wkly Rep 2006, 55:121\u2013125.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2_CR77","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.tripleo.2004.10.011","volume":"100","author":"M. Navazesh","year":"2005","unstructured":"Navazesh M, Mulligan R, Pogoda J, et al.: The effect of HAART on salivary microbiota in the Women\u2019s Interagency HIV Study (WIHS). Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005, 100:701\u2013708.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2_CR78","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1014443418737","volume":"11","author":"I.D. Coulter","year":"2002","unstructured":"Coulter ID, Heslin KC, Marcus M, et al.: Associations of self-reported oral health with physical and mental health in a nationally representative sample of HIV persons receiving medical care. Qual Life Res 2002, 11:57\u201370.","journal-title":"Qual Life Res"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-008-0002-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11904-008-0002-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-008-0002-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T21:07:29Z","timestamp":1708549649000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11904-008-0002-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["2"],"URL":"https:\/\/doi.org\/10.1007\/s11904-008-0002-8","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}